InMed Pharmaceuticals, Inc. (INM)
0.634
-0.02
(-3.21%)
USD |
NASDAQ |
May 13, 16:00
InMed Pharmaceuticals Gross Profit (TTM) : 0.5836M for March 31, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| CannaPharmaRx, Inc. | -2.085M |
| Lexaria Bioscience Corp. | 0.2804M |
| Target Group, Inc. (Canada) | 1.170M |
| Tilray Brands, Inc. | 203.46M |
| NervGen Pharma Corp. | -0.0399M |